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Abstract
Motivation: DNA methylation datasets are growing ever larger both in sample size and genome
coverage. Novel computational solutions are required to efficiently handle these data.
Results: We have developed meffil, an R package designed for efficient quality control, normaliza-
tion and epigenome-wide association studies of large samples of Illumina Methylation BeadChip
microarrays. A complete re-implementation of functional normalization minimizes computational
memory without increasing running time. Incorporating fixed and random effects within functional
normalization, and automated estimation of functional normalization parameters reduces technical
variation in DNA methylation levels, thus reducing false positive rates and improving power.
Support for normalization of datasets distributed across physically different locations without
needing to share biologically-based individual-level data means that meffil can be used to reduce
heterogeneity in meta-analyses of epigenome-wide association studies.
Availability and implementation: https://github.com/perishky/meffil/
Contact: josine.min@bristol.ac.uk or matthew.suderman@bristol.ac.uk
Supplementary information: Supplementary data are available at Bioinformatics online.
1 Introduction
DNA methylation is the addition of methyl groups to cytosine bases in
the DNA sequence, most often in the context of a CpG dinucleotide, a
cytosine followed by a guanine. The addition or loss of methyl groups
is often associated with changes in gene expression, and through epi-
genome wide associations studies (EWAS) it has been shown to associ-
ate with a wide range of complex traits. A number of technologies
have been developed for interrogating DNA methylation including
microarrays and sequencing-based methods. The Illumina Infinium
HumanMethylation450 BeadChip (450k array) can be used to meas-
ure DNA methylation of 485k CpG sites, comprising just under 2%
of the total genomic CpG content mainly clustered around the tran-
scription start sites (Michels et al., 2013). The new Illumina Infinium
MethylationEPIC BeadChip (EPIC array) expands this coverage to
850k sites to include enhancer regions identified by ENCODE
(Hong et al., 2016) and FANTOM5 (Andersson et al., 2014).
Batch effects present a well-known challenge to microarray ana-
lysis (Teschendorff et al., 2011), particularly in datasets composed
of thousands of samples since they cannot all possibly be processed
at the same times and by the same technical personnel (Leek et al.,
2010). This unwanted variation can increase both false negative and
false positive rates if correlated with the outcome of interest, and
controlling for this is not trivial, especially as sample sizes continue
to grow.
Following the popularity of quantile normalization for analyzing
gene expression microarrays (Bolstad et al., 2003), many variations
based on quantile normalization have been developed for DNA
methylation microarrays (Lehne et al., 2015; Teschendorff et al.,
2013; Touleimat and Tost, 2012), however, all assume that global
methylation does not vary between samples (Hicks and Irizarry,
2015). When this does not hold, most notably between tumor and
normal samples, between different tissue types, or when there are
batch differences between cases and controls, quantile normalization
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can remove biological variation along with technical variation [e.g.
(Fortin et al., 2014b; Heiss and Brenner, 2015)]. A feature of 450k
and EPIC arrays is the inclusion of control probes–probes that do
not assay biological variation and only vary due to technical effects.
Functional normalization (FN; Fortin et al., 2014b) exploits control
probes to separate biological variation from technical variation, and
its performance compares favorably to other approaches (Fortin
et al., 2014b; Heiss and Brenner, 2015; Lehne et al., 2015; Liu and
Siegmund, 2016; Maksimovic et al., 2015).
Many DNA methylation datasets using 450k and EPIC arrays
have now been generated independently and are being used in
EWAS to discover associations between CpG sites and a variety of
exposures, complex traits and disease risks. Much like genome-wide
association studies (GWAS), the widespread use of the Illumina plat-
form has made possible large-scale meta-analyses organized by
international consortium-based efforts that are combining ever
larger numbers of subjects to reach statistical power to detect robust
associations. However, unlike GWAS, it comes with a number of
crucial challenges that have not been fully resolved. First, most exist-
ing software tools for quality control and normalizing DNA methy-
lation levels were not designed to handle datasets comprising
thousands of samples, and recently developed tools in R (Gorrie-
Stone, 2018) and Java (Almeida et al., 2017) may not provide
desired functionality. Second, sharing of individual-level data is pro-
hibited due to ethical considerations, so meta-analyses are liable to
encounter heterogeneity introduced when datasets are normalized
independently. Third, there is currently no universally accepted
standard approach that addresses all aspects of dataset quality con-
trol and normalization of large datasets. Fourth, there is no standar-
dized approach for selecting and comparing statistical models for
EWAS, including selection and generation of covariates. Fifth, there
is currently no standard for sharing quality control information and
EWAS findings.
We have developed meffil (Efficient algorithms for analyzing
DNA methylation data) to provide solutions in a user-friendly
and open source R package (https://github.com/perishky/meffil).
Figure 1 shows the meffil work-flow from raw data to quality con-
trol to normalized data to EWAS. Meffil includes functionality for
identifying low quality methylation measurements, discovering and
rectifying sample mismatches, merging datasets containing both
450k and EPIC arrays, removing confounding effects of cell type
heterogeneity and assessing the quality of observed associations.
In this paper, we describe its implementation and evaluate the
computational and statistical advantages that it achieves, while dem-
onstrating where limitations might still exist.
2 Materials and methods
2.1 Data
Full details of the Accessible Resource for Integrated Epigenomic
Studies (ARIES; Relton et al., 2015) and Genetics of Overweight
Young Adults (GOYA; Paternoster et al., 2011) datasets are pro-
vided in the Supplementary Material. DNA methylation was
quantified in bisulfite-converted genomic DNA using 450k arrays
for all samples. Some samples were removed due to genotype and
gender mismatches and methylation quality (low detection scores,
low number of beads, methylated/unmethylated ratio, strong
dye-bias, post-normalization checks). Samples were normalized
using FN using meffil. After normalization we checked for batch
effects including bisulfite-conversion plate (‘plate’) and beadchip
(‘slide’).
2.2 Implementation of meffil
Meffil is designed around a re-implementation of FN as imple-
mented in the minfi R package (Fortin et al., 2014b). Output using
default settings and without enhancements is therefore identical to
minfi (Aryee et al., 2014). Meffil uses the illuminaio R package
(Smith et al., 2013) to parse Illumina IDAT files into QC objects
(Fig. 1) which contain raw control probe summaries, quantile distri-
butions of raw probe intensities, poor quality probes based on detec-
tion P-values and number of beads, predicted sex (Aryee et al.,
2014), predicted cellular composition (Houseman et al., 2012) when
a cell type reference is specified and batch variable values. As in
minfi, probe intensities are dye-bias and background corrected using
the ‘noob’ method (Triche et al., 2013). Control probes are summar-
ized as 42 different control types in a control matrix with one row
for each control type and one column for each sample.
This summary object is all that is needed to perform quality con-
trol, sample and CpG site filtering, identification of batch effects
and the normalization of sample quantiles, the first normalization
step of FN. In this step, probe intensity quantiles are normalized be-
tween samples by fitting linear models with these quantiles to the
top principal components of the control matrix. The resulting quan-
tile residuals for each QC object are retained as a set of normalized
quantiles which are then used in the second normalization step
where the raw probe intensities for each sample are adjusted to con-
form to its set of normalized quantiles.
This memory-reducing innovation makes it possible to perform
the second normalization step on small subsets of the dataset, each
at different times or on different compute servers. Parallelization of
the normalization is possible when either a single compute server
has multiple processors or the normalization is being performed on
a compute cluster. After the second normalization step has been
completed for each individual sample, the resulting normalized
methylation data subsets may be merged into a single dataset for
DNA methylation analyses. The order of or server on which the
samples were normalized does not affect the final normalized values
in any way.
2.3 Quality control features
In meffil, quality control reports can be generated in order to un-
cover variation due to technical artefacts, identify outliers and flag
poor quality probes and samples using detection P-values, number
of beads, ratio of unmethylated/methylated signal, dyebias and
Raw data (IDAT files)
QC objects
Parameter metrics
Normalized data
Normalized objects
QC report
Normalization report
Remove outliers
EWAS statistics EWAS report
QC data 
extraction
Normalize 
quantiles
Probe quantile 
normalization
Association
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Full data 
extraction
Fig. 1. The workflow of meffil
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control probe checks. The report also provides checks for
sample swap detection using SNP discordance between methyla-
tion and genotype arrays as well as a gender check (Supplementary
Fig. S1).
Meffil generates a normalization report with coefficients plots
comparing the strength of associations between batch variables with
control probes and with normalized data. The report contains a
table with ANOVA F and post-hoc t-statistics that pass a user-
defined significance threshold to identify problematic batches, e.g. a
specific slide with technical artefacts that are not sufficiently
resolved by normalization (Supplementary Fig. S2). All reports are
generated in markdown and HTML.
2.4 Extending FN to reduce technical variation
Meffil provides two new features to reduce technical variation:
(i) a method to identify the number of principal components
that minimizes the residual variance unexplained by the given
number of principal components. Residual variance is calculated
under a 10-fold cross-validation scheme in order to avoid
overfitting. (ii) We observed that FN failed to completely remove
the variance due to certain technical artefacts such as sample
slide or slide row. To address this, we allow the user to normalize
sample quantiles using additional fixed and random effects.
Random effects are handled using the lme4 R package (Bates et al.,
2015).
2.5 EWAS pipeline
To deliver a comprehensive and integrated toolkit for methylation
analysis, meffil also provides an EWAS pipeline. Linear regression
models are fitted using limma (Ritchie et al., 2015). Confounding
effects are handled by including appropriate covariates in the
EWAS. By default, meffil fits four different regression models: no
covariates, only supplied covariates, supplied and surrogate varia-
bles obtained by surrogate variable analysis (SVA; Leek et al., 2012;
Leek and Storey, 2007) and supplied and surrogate variables
obtained by independent surrogate variable analysis (ISVA;
Teschendorff et al., 2011). Meffil allows estimation of cellular com-
position using the Houseman algorithm (Houseman et al., 2012)
from DNA methylation profiles based on several publicly available
blood reference datasets including three cord blood references
(Bakulski et al., 2016; de Goede et al., 2015; Gervin et al., 2016)
and one peripheral blood reference (Reinius et al., 2012) or from
user-supplied references.
EWAS results are summarized in a report that includes quantile-
quantile, Manhattan, covariate and variable-of-interest plots as well
as tables and scatterplots showing the strongest as well as user-
defined candidate CpG site associations. Outputs are displayed to
allow comparison between each of the different EWAS models
(Supplementary Fig. S3).
2.6 Analysis that protects study participant privacy
Because the control probes capture only technical variation, they are
fundamentally non-disclosive. It is possible to use meffil to normal-
ize datasets residing on distinct servers together while sharing only
the control probe summaries and probe intensity quantiles between
the two servers. This information cannot be used to identify individ-
uals and should not violate most cohort participant privacy agree-
ments. Actual phenotype or DNA methylation levels need never be
shared.
3 Results
3.1 Automated normalization for heterogeneous data
with improved computational efficiency
3.1.1 Computational efficiency
Our original motivation for creating meffil was an inability to suc-
cessfully normalize 5400 450k arrays using available software
tools and computational resources. The main impediment was the
large memory requirement of loading all data into memory before
normalization could be initiated. We discovered, however, that FN
(Fortin et al., 2014b) could be reimplemented in a way that uses a
small fraction (1/20) of the memory required by the entire dataset.
In particular, we realized that FN could be completed one sample at
a time while holding in memory a relatively small summary of probe
intensities for each sample. The summary consists of a control probe
matrix and probe intensity quantiles. After the summary has been
collected, FN then proceeds to normalize intensity quantiles by
removing control probe variation. Normalized methylation levels
for each sample can then be derived from the normalized quantiles
independently of all other samples.
To minimize running time, the meffil implementation makes use
of the R parallel package (R Core Team, 2014) to allow normaliza-
tion of multiple samples simultaneously. Normalization of 5469
450k arrays took 3 h on a compute server with 64 Gb of RAM and
16 processors. A comparison shows that the memory requirements
to normalize the same dataset using another popular software tool,
minfi, were much larger (Table 1). Most other popular packages
(Assenov et al., 2014; Morris et al., 2014) that provide FN capabil-
ity are simply wrappers for the minfi implementation. Two recently
developed tools, bigMelon (Gorrie-Stone, 2018) and DiMmeR
(Almeida et al., 2017) were also specifically designed to normalize
large datasets. Although neither implements FN, we provide their
performance characteristics for comparison.
3.1.2 Scalable pipeline and reporting mechanisms
Normalization and analysis of datasets, particularly large datasets,
is rarely automatic and requires interactive problem-solving. Ideally,
Table 1. Comparison between software packages on a server with
16 available processors
meffil minfi meffil bigMelona bigMelonb diMmeR
Number of
samples
1000 1000 5469 5469 5469 5469
Normalization
method
FN FN FN Dasen Dasen QN
Platform R R R R R Java
Size of summary
(Gb)c
0.2 0.8
Memory (Gb) 3/5d 15 3/67d 57 12 4.4
Time (min) 16 54 180 350 450 82
Size of output
(Gb)e
3.5 2.8 17 90 90
abigMelon applied with chunksize set to 500.
bbigMelon applied with chunksize set to 100.
cOnly meffil generates a summary object.
dIf the output from meffil is a matrix in R, then memory use peaks at
67 Gb. If the output is saved to ‘gdsfmt’(Zheng et al., 2012, 2017) file like
bigMelon, then the memory use peaks at 3 Gb. We note that the running time
will be the same for both options.
eDimMeR does not save output until after a permutation-based EWAS is run.
We terminated analysis after normalization so output size was not determined.
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then, analysis tools should reflect this, allowing for some level of
automation while also allowing high-level tasks to be broken down
into more specific tasks with customizable solutions. Graphical user
interface packages, which are most convenient for users, are often
not available on computational servers or high-performance com-
puting cluster. Graphical interfaces like shinyMethyl (Fortin et al.,
2014a) and MethylAid (van Iterson et al., 2014) handle this problem
by extracting data summaries that can be loaded and manipulated
on a desktop computer. In meffil, we address this challenge by pro-
viding functions that nearly completely automate the entire process
but can be replaced with calls to sets of functions that allow more
detailed interaction with data processing. After each main process-
ing step (quality control, normalization and EWAS), HTML reports
are generated that summarize the results of each (Supplementary
Figs S1–S3), allowing the user to evaluate the success of each step
before proceeding to the next and to share with collaborators. We
also provide extensively tested quality control protocols on the mef-
fil wiki website (https://github.com/perishky/meffil/wiki). We note
that EWAS in meffil actually fits four different regression models:
no covariates and user-supplied covariates with or without surrogate
variables obtained by applying SVA or ISVA.
3.1.3 Analysis of mixed 450k and EPIC datasets
Given the large number of datasets that have 450k DNA methyla-
tion profiles and the apparent popularity of the new EPIC micro-
array, it will likely be necessary to merge 450k and EPIC datasets
for analysis. This is made possible in meffil by applying identical
methods to probes common to both microarrays. We have yet to as-
sess the performance of this approach due to the lack of an available
mixed dataset. Fortin et al., 2017 have made a first attempt using
the minfi package but their assessment dataset includes only three
EPIC microarrays supplied by the manufacturer.
3.2 Extending FN to reduce technical variation
To assess the performance of new features in meffil we processed
raw data from ARIES (Supplementary Methods). Although the ut-
most care was taken in the generation of the high-quality methyla-
tion profiles in ARIES, practical constraints lead to inconsistencies
in the way samples were collected and processed. For example,
DNA was extracted from a variety different sample types: whole
blood, white cells, peripheral blood lymphocytes and blood spots,
each with slight differences in the resulting methylation measure-
ments. We exploit this heterogeneity to evaluate the performance of
FN. An EWAS of pre-natal tobacco exposure was then applied to
the cord blood samples comprising white cells and bloodspots
(n¼777). To ensure that our observations weren’t specific to ARIES
given the differences between sample starting material (e.g. blood
spots versus white blood cells), we repeated the analysis in the
GOYA study (Paternoster et al., 2011; Supplementary Methods).
Performance was assessed by comparing resulting association statis-
tics in the two datasets to 5801 associations of a large EWAS meta-
analysis of pre-natal smoking (Joubert et al., 2016). As there are
multiple options for selecting covariates to include in the EWAS re-
gression model, we considered three options: no covariates, cellular
composition estimates from cord or adult blood panels plus other
covariates and surrogate variables obtained using ISVA (Leek and
Storey, 2007; Teschendorff et al., 2011). Consistent with previous
findings, ISVA surrogate appear to sufficiently account for most
confounding factors including heterogeneity of cellular composition
(McGregor et al., 2016) resulting in highly sensitive and specific
EWAS findings (Supplementary Fig. S4).
3.2.1 Extending FN to include fixed and random effects
We and others (Akulenko et al., 2016) have found that FN often
fails to completely remove slide and plate effects (Supplementary
Table S1). Slide effects occur because groups of samples are meas-
ured using the same glass slide or bead chip (12 samples per slide for
450 K microarrays and 8 per slide for EPIC microarrays). Plate
effects occur because groups of samples are bisulfite converted on
the same 96-well plate. We therefore revised our implementation of
FN to allow additional fixed and random effects to be included with
the control probe summaries.
Normalization reports for ARIES showed a large drop in batch-
associated variation after including batch (slide) as a random effect
in FN. It was not possible to model batch as a fixed effect because
induced group sizes were too small. When we performed an EWAS
of pre-natal tobacco exposure in the resulting normalized version of
ARIES, we observed increased specificity and sensitivity to detect
previously meta-analyzed associations (Joubert et al., 2016; Fig. 2).
Area under the curve (AUC) increased in ARIES (0.63 to 0.65,
P<2.2 x 1016, DeLong’s test) and in GOYA (when including plate
as a random effect; 0.58 to 0.59, P¼1.8 x 107). For comparison,
we also applied a random effects EWAS to FN normalized data.
Including slide as a random effect in an EWAS of ARIES was not an
improvement over our extension of FN (AUC decreased from 0.65
to 0.64, P¼1.8 x 106), however including plate as a random effect
in an EWAS of GOYA was an improvement (AUC increased from
0.59 to 0.61, P<2.2 x 1016). All receiver operating characteristic
(ROC) curves are shown in Figure 2. Users could use a similar ap-
proach using the normalization report and well-established EWAS
findings to make normalization decisions.
3.2.2 Automated parameter selection
FN has one main parameter that can be set by the user: the number
of principal components (maximum¼42) derived from control fea-
tures to be used to normalize the probe quantiles (Fortin et al.,
2014b). The default number advised by Fortin et al., 2014b is two,
derived as the number maximizing discovery of differentially methy-
lated signals in a few examples. In meffil, we implemented an ap-
proach that estimates the number of principal components as the
number that best explains variation in the probe intensity quantiles.
This test is performed under cross validation in order to avoid over-
fitting (Supplementary Material).
To evaluate the performance of the automatic parameter selec-
tion, we generated nine normalizations of ARIES and GOYA cord
blood samples, each normalized with a different number of control
Fig. 2. Effect of adjusting ‘slide’ or ‘plate’ as a random effect. True positive
rates (TPRs) are consistently higher in a downstream EWAS when variation
due to ‘slide’ effects in ARIES (a) and ‘plate’ effects in GOYA (b) are removed
using random effects models. Random effects models were applied either
probe quantiles along with control variation in FN (‘FNþre’) or during the
EWAS (‘FNþewas.re’). TPRs were estimated by comparison to associations
from a large meta-analysis (Joubert et al., 2016)
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summary principal components and evaluated the sensitivity and
specificity of identifying associations with pre-natal tobacco expos-
ure. ROC curves show that parameter choice can have a large influ-
ence (Fig. 3a and b), with the recommended choice of 10 returning
the best performance.
3.2.3 Reducing heterogeneity in Meta-analyses with minimal data
sharing
Due to the way that FN is re-implemented in meffil, it is possible to
normalize datasets residing on distinct servers together while sharing
only the control probe summaries and probe intensity quantiles be-
tween the two servers (Fig. 4a). We evaluated the effect of this ap-
proach on heterogeneity in a meta-analysis of age in seven publicly
available DNA methylation datasets (n¼2967, Supplementary
Table S2, Supplementary Methods). In a first meta-analysis, each
dataset was normalized separately and, in a second meta-analysis
(the ‘mega’ EWAS), the datasets were normalized together (Fig. 4a).
Heterogeneity was compared between meta-analyses by paired t-test
of tau2 (Rucker et al., 2008) to only those CpG sites associated with
age in an EWAS of all datasets merged together (Bonferroni adjusted
P<0.05 and at least 0.1% change in methylation per year). In each
EWAS surrogate variables generated either by ISVA or SVA were
used as covariates. The ISVA mega EWAS identified 2487 CpG sites
associated with age (Bonferroni adjusted P<0.05 and absolute
value of the regression coefficient greater than 0.1% per year)
whereas the SVA mega EWAS identified 7697 sharing 1773 associa-
tions. The regression coefficients of the pooled set of 8411 associa-
tions were highly correlated between them (R¼0.91).
Using ISVA, heterogeneity was actually lower when datasets
were normalized separately prior to meta-analysis (mean tau2
difference ¼ 1.2 x 107, P<7.7 x 1054; Fig. 4b). Conversely, when
SVA was used, heterogeneity was much lower when datasets were
normalized together (mean tau2 difference ¼ 2.4 x 108; P<1.4 x
10194; Fig. 4b).
Agreement between meta-analyzed and mega EWAS was also
highly covariate-dependent and followed expectations that reduced
heterogeneity led to greater agreement. Agreement was quantified
by treating the mega EWAS associations as the true set of associa-
tions and calculating the false discovery rate (FDR) and TPR of the
corresponding meta-analysis. For ISVA-based EWAS, FDR was
35% and TPR was 63% when datasets were normalized separately.
When datasets were normalized together, FDR was slightly higher
(36%) and TPR lower (49%). For SVA, FDR was much lower at
6% and TPR much higher at 78% when datasets were normalized
separately. When datasets were normalized together, FDR was
slightly lower (4%) and TPR slightly higher (81%). From these
results, we conclude that normalization prior to meta-analysis may
improve results but this is not guaranteed.
3.3 Perfect confounding between batch effects and
biological phenotypes is not resolved by functional
normalization
A common problem in epidemiological datasets is perfect confound-
ing with batch, particularly for opportunistic case-control studies in
which data is generated for cases subsequent to data collected from
a control population. We evaluated the efficacy of FN to remove
only technical variation based on control variation while leaving
biological variation intact. To test this, we compared methylation
differences between methylation profiles obtained from cord blood
against peripheral blood collected in adolescence under two scen-
arios, one in which there was perfect confounding with batch (e.g.
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Fig. 3. Parameter selection for FN. The main parameter for FN is the number
of principal components of control variation with which to normalize probe
quantiles. Screeplots (a, b, d, e) show the metric used to meffil for choosing
the optimal number of principal components in ARIES (a, b, c) and GOYA
(d, e, f), the amount of probe quantile variation unexplained by the principal
components under 10-fold cross validation. The explained variation is mainly
due to technical variance as the control probes should not be correlated with
biological signal (Supplementary Material). Screeplots (a, d) show the vari-
ation without regressing out random effects whereas plots (b) and (e) show
the variation after regressing out slide (b) or plate (e) as random effect. Plots
(c) and (f) compares true and false positive rates in a downstream EWAS of
pre-natal smoking in ARIES (c) and GOYA (f) after normalizing with different
numbers of principal components and regressing out slide or plate as a
random effect. TPRs were estimated by comparison to associations from a
large meta-analysis (Joubert et al., 2016)
Fig. 4. Meta-analysis with normalized data. Data can be normalized using
meffil as illustrated in (a) by generating QC objects for each dataset, sending
them to a normalization server for normalization and then sending them back
to each dataset to complete normalization of each sample. (b) The heterogen-
eity tau2 statistic is shown for CpG sites in the meta-analyses of age per-
formed with and without normalizing the seven datasets together prior to
meta-analysis. The top plot shows heterogeneity when ISVA is used to gener-
ate surrogate covariates and the bottom plot when SVA is used instead. CpG
sites shown in the plot are those identified as associated with age in the
EWAS of the combined dataset, 2486 associations for ISVA and 7697 for SVA.
The dark diagonal line shows y¼x and the grey line the regression line
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GOYA cord against ARIES adolescence) and another in which batch
was randomized (e.g. ARIES cord versus ARIES adolescence). In the
unconfounded analysis, only 14 DNA methylation differences were
identified (Bonferroni adjusted P<0.05) after adjusting for hetero-
geneity in cellular composition. In contrast, in the confounded ana-
lysis, there were 38 950 methylation differences and this included
only seven of the 14 differences from the unconfounded analysis. Of
the 38 950, 62% had effect sizes in the same direction as in the
unconfounded analysis. This suggests that the vast majority of the
38 950 were false positives.
We then asked if adjusting for controls directly in the EWAS re-
gression model would reduce the number of apparent false positives
while retaining some of the true positives. Under this model we
obtained 199 differentially methylated CpG sites, of which 50 over-
lapped with the 38 950 from the confounded analysis and none with
the unconfounded analysis. Of the 199 123 (62%) agreed on the dir-
ection of association. Once again, these results suggest that most or
all of the 199 were false positives. This was not due to the control
probes failing to fully account for batch variation as a few of the
‘hybridization’ controls perfectly differentiated between batches.
The false positives were then possibly due to model instability due
to high correlation between controls and the variable of interest.
4 Discussion
Illumina Infinium DNA methylation microarrays have been used in
a number of large-scale epigenetic epidemiological studies due to
their low cost and large coverage of the genome. Despite the exten-
sive use of these arrays, memory efficient and comprehensive soft-
ware are currently lacking. We have designed meffil to perform pre-
processing, quality control, data harmonization, normalization and
EWAS easily, flexibly and memory-efficiently. We have demon-
strated that meffil can remove unwanted variation both using FN
and by including covariates in EWAS models. Automatic generation
of comprehensive reports at each step allows users to assess the suc-
cess of each and potentially repeat steps after tweaking parameters
to improve performance. The possibility of normalizing remote
datasets together without sharing sensitive information may help to
reduce heterogeneity in meta-analysis.
To evaluate different settings in meffil, we used the ARIES and
GOYA datasets and compared associations with pre-natal tobacco
exposure under various normalization schemes against those pub-
lished for a large meta-analysis (Joubert et al., 2016) as an example.
A limitation of this approach is that the meta-analyzed set of associ-
ations might be contaminated with false positives due to batch and
confounding effects that replicate across meta-analyzed datasets.
Although the meta-analysis appears to be well-powered and there-
fore able to identify associations with small effect sizes, there are un-
doubtedly false negatives due to the variety of different data
generation, quality control and normalization procedures applied to
meta-analyzed datasets. Furthermore, all studies relied on self-
reported smoking during pregnancy.
We used pre-natal smoking where multiple loci with small effect
sizes contribute to the phenotypic variance rather than large case
control effects (such as cancer). As batch effects will have the largest
impact on such small effects, correcting for these effects in the most
optimal way will improve power. In addition, integration and har-
monization across different studies will lead to increased power in
EWAS. However, simulations with different sizes of batch, con-
founder and case control effects are required to find out which
method and settings work best but are not the scope of this paper.
Especially, as for most traits the genomic architecture is unknown,
different assumptions should be made for different traits.
We and others (Akulenko et al., 2016) have noted that FN may
fail to completely remove certain technical effects, either because
that variation is missing from microarray controls or because probe
quantiles rather than probe intensities are directly adjusted. To
address the former possibility, we allow the user to include addition-
al technical variables as fixed or random effects. As shown in
Supplementary Table S1, the addition of a random ‘slide’ effect does
indeed reduce variation associated with ‘slide’. For this reason, it
might be better in some cases to employ a different normalization
method. Crucially, we demonstrate that though FN attempts to sep-
arate technical from biological variation, when batch and phenotype
are perfectly confounded results can be extremely unreliable. We
recommend that cases and controls be assayed jointly within a single
experiment in a random order.
Reducing heterogeneity in meta-analysis is likely to increase
power to observe associations. Although we hypothesized that nor-
malizing between datasets prior to meta-analysis could reduce het-
erogeneity, our analyses show that this cannot always be assumed
and may depend on the regression models used for EWAS, at least
for FN. Further work is needed to better understand the conditions
necessary for reducing heterogeneity by normalization.
We plan in future to provide alternative background subtraction
and normalization approaches, re-implemented in order to preserve
the current low memory requirements of meffil and ability to nor-
malize datasets present on distinct servers. We note however that for
some methods, the re-implementation will not produce identical
results because they depend on the entire dataset being loaded into
memory [e.g. (Lehne et al., 2015)]. For specific parts of the normal-
ization pipeline, we plan to offer means for users apply their own
custom R code. Future directions also include the possibility of inte-
grating meffil within systems like DataShield (Gaye et al., 2014)
that will allow not only combined normalization but also EWAS of
datasets present on distinct servers. This will improve both the
power of and the speed at which meta-analyses of multiple cohort
studies can be completed.
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